Gault Laura bought SAGE
February 13, 2024 · Form 4 insider transaction
Gault Laura bought 22,500 shares of SAGE Therapeutics Holdings at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
22,500
Price
$0.00
Total value
N/A
InsiderGault Laura
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 13, 2024
Filing dateFebruary 15, 2024
Shares owned after22,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The securities awarded on February 13, 2024 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,625 shares of common stock shall vest on the one year anniversary of February 13, 2024, with 16,875 shares vesting in 36 equal monthly installments thereafter.